Consumer durables is a cataloguing of consumer goods that are not essential to be bought very often as they are fashioned in a way so as to last for an extended period of time. Profits in the consumer durables sector were most profoundly…
BMI View: The Irish government's four-year agreement with the pharmaceutical industry with regard to
drug pricing reflects the government's continued focus on cost control measures targeting pharmaceutical
expenditure. The agreed price-reduction mechanism for existing medicines will, however, allow for the
prioritisation of funding toward ensuring access to new, innovative medicines. While the pharmaceutical
market will continue to decline in value terms, Ireland's robust long-term economic outlook will continue to
support healthcare expenditure expansion. Rising demand for healthcare will be reflected in rising private
health insurance uptake.
Headline Expenditure Projections
? Pharmaceuticals: EUR2.32bn (USD2.53bn) in 2015 to EUR2.27bn (USD2.50bn) in 2016;-2.0% in local
currency terms and -1.0% in US dollar terms. Forecast in line in local currency terms and revised
upwards in US dollar terms from last quarter.
? Healthcare: EUR15.08bn (USD16.42bn) in 2015 to EUR15.48bn (USD17.03bn) in 2016; +2.7% in local
currency terms and 3.7% in US dollar terms. Forecast revised upwards from last quarter.